Share: Facebook Twitter LinkedIn
Activity Provided By:

Integritas Communications

Hot Topics in Lupus: SLE Pathophysiology

Access Activity

Overview / Abstract:

Despite the known short- and long-term adverse outcomes related to glucocorticoid use, patients with SLE are still taking moderate to high daily doses of steroids. Fortunately, 2 biologic therapies aimed at different therapeutic targets in the type I interferon pathway and with better safety profiles than glucocorticoids are currently available for use. These biologics, along with off-label immunosuppressants, can be implemented in customized ways to mitigate or eliminate the use of glucocorticoids in patients with SLE. In this Hot Topics series, an expert rheumatologist will provide focused education on the clinical profiles of currently available biologic therapies and best practices for individualizing disease management in patients with SLE. Utilizing an engaging delivery format that combines graphics and video, this educational series meets the needs of busy clinician learners who wish to stay current on the evolving best practices in managing patients with SLE.


May 30, 2024


Nurse Practitioner , Physician CME, Physician Assistant CME


Webinar / Webcast / Video

Credits / Hours




Presenters / Authors / Faculty

Elena M. Massarotti, MD
Associate Professor of Medicine
Harvard Medical School
Director of Clinical Lupus Trials, Division of Rheumatology
Vice Chair of Clinical Affairs, Department of Medicine
Brigham and Women’s Hospital
Boston, Massachusetts

Sponsors / Supporters / Grant Providers

This activity is provided by Integritas Communications.

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Keywords / Search Terms

Integritas Communications lupus, SLE, rheumatology, systemic lupus erythematosus, pathophysiology Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map